Search alternatives:
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
ms decrease » _ decrease (Expand Search), mean decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i wt » _ wt (Expand Search), i w (Expand Search), i et (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
ms decrease » _ decrease (Expand Search), mean decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i wt » _ wt (Expand Search), i w (Expand Search), i et (Expand Search)
-
241
-
242
Main components of bauxite and BCFD (wt.%).
Published 2025“…The desilication reaction follows a solid shrinkage core model, with a kinetic equation of 1−2/3α−(1−α)<sup>2/3</sup> = 15.50exp[−29299/(RT)]·t, and an apparent activation energy of 29.30 kJ/mol. …”
-
243
-
244
-
245
-
246
-
247
-
248
-
249
-
250
-
251
-
252
-
253
-
254
<i>Mertk</i><sup><i>-/-</i></sup> macrophages exhibit unpolarized distribution of filamentous actin and myosin II, and decreased FAK phosphorylation.
Published 2015“…<p>Peritoneal macrophages from the WT (A) and <i>Mertk</i><sup><i>-/-</i></sup> (B) mice were prepared following the procedure described in the <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0117787#sec002" target="_blank">Materials and Methods</a>. …”
-
255
-
256
Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.
Published 2016“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
-
257
-
258
-
259
-
260